Cargando…
666 Ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice treated with human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid lipid nanoparticle
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Cystic Fibrosis Society.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527896/ http://dx.doi.org/10.1016/S1569-1993(22)01356-X |
| _version_ | 1784801175626842112 |
|---|---|
| author | Mukherjee, A. MacDonald, K. Eygeris, Y. Lokras, A. Sahay, G. |
| author_facet | Mukherjee, A. MacDonald, K. Eygeris, Y. Lokras, A. Sahay, G. |
| author_sort | Mukherjee, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9527896 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Cystic Fibrosis Society. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95278962022-10-03 666 Ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice treated with human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid lipid nanoparticle Mukherjee, A. MacDonald, K. Eygeris, Y. Lokras, A. Sahay, G. J Cyst Fibros Posters European Cystic Fibrosis Society. 2022-10 2022-10-03 /pmc/articles/PMC9527896/ http://dx.doi.org/10.1016/S1569-1993(22)01356-X Text en Copyright © 2022 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Posters Mukherjee, A. MacDonald, K. Eygeris, Y. Lokras, A. Sahay, G. 666 Ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice treated with human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid lipid nanoparticle |
| title | 666 Ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice treated with human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid lipid nanoparticle |
| title_full | 666 Ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice treated with human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid lipid nanoparticle |
| title_fullStr | 666 Ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice treated with human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid lipid nanoparticle |
| title_full_unstemmed | 666 Ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice treated with human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid lipid nanoparticle |
| title_short | 666 Ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice treated with human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid lipid nanoparticle |
| title_sort | 666 ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice treated with human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid lipid nanoparticle |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527896/ http://dx.doi.org/10.1016/S1569-1993(22)01356-X |
| work_keys_str_mv | AT mukherjeea 666ivacaftorboostscysticfibrosistransmembraneconductanceregulatormediatednasalpotentialdifferenceincysticfibrosistransmembraneconductanceregulatorknockoutmicetreatedwithhumancysticfibrosistransmembraneconductanceregulatormessengerribonucleicacidlipidnanop AT macdonaldk 666ivacaftorboostscysticfibrosistransmembraneconductanceregulatormediatednasalpotentialdifferenceincysticfibrosistransmembraneconductanceregulatorknockoutmicetreatedwithhumancysticfibrosistransmembraneconductanceregulatormessengerribonucleicacidlipidnanop AT eygerisy 666ivacaftorboostscysticfibrosistransmembraneconductanceregulatormediatednasalpotentialdifferenceincysticfibrosistransmembraneconductanceregulatorknockoutmicetreatedwithhumancysticfibrosistransmembraneconductanceregulatormessengerribonucleicacidlipidnanop AT lokrasa 666ivacaftorboostscysticfibrosistransmembraneconductanceregulatormediatednasalpotentialdifferenceincysticfibrosistransmembraneconductanceregulatorknockoutmicetreatedwithhumancysticfibrosistransmembraneconductanceregulatormessengerribonucleicacidlipidnanop AT sahayg 666ivacaftorboostscysticfibrosistransmembraneconductanceregulatormediatednasalpotentialdifferenceincysticfibrosistransmembraneconductanceregulatorknockoutmicetreatedwithhumancysticfibrosistransmembraneconductanceregulatormessengerribonucleicacidlipidnanop |